温氏股份(300498.SZ)漲近4% 2019年淨利潤預增249%-261%
格隆匯1月7日丨昨晚發盈喜的温氏股份(300498.SZ)今日跳空高開高走,為連續第7日上漲,現報37.22元,漲3.88%,暫成交7.75億元,最新總市值1976億元。公司昨晚公告稱,預計2019年度實現淨利潤為138.5億元至143億元,同比增249.97%-261.35%。報告期內,公司銷售肉豬1851.66萬頭(含毛豬和鮮品),同比下降16.95%,但是銷售價格同比上漲46.57%;銷售肉雞9.25億隻(含毛雞、鮮品和熟食),同比增長23.58%,銷售均價同比上漲9.93%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.